Key result
Disulfiram shows anticancer potential by chelating intracellular copper to form cytotoxic complexes.
Why the study?
Disulfiram is of great interest as an antitumor agent due to its ability to form cytotoxic complexes with copper, which is elevated in many cancer cells.
Does disulfiram cause cytotoxicity in cancer cells with elevated copper levels?
Does disulfiram cause cytotoxicity in cancer cells with elevated copper levels?
Answers are grounded in this paper and cite their sources.
Disulfiram, an FDA-approved drug for alcoholism, is of great interest in cancer research as a potential antitumor agent due to its ability to bind copper and induce cytotoxicity in cancer cells.
Disulfiram (tetra ethyl thiuram disulfide, or DSF), is a disulfide derivative of N, N-diethyl dithiocarbamate (DEDTC). DSF is an FDA approved drug for the treatment of alcoholism, and at low doses continues to be a useful treatment option for those suffering from the disease. DSF is a member of the dithiocarbamate family, and is thus a metal chelator. Many cancer cells have elevated levels of copper, a metal to which DSF can bind. Thus, DSF is of great interest in cancer research as an antitumor agent, as studies suggest the DSF-copper complex may be cytotoxic to cancer cells. This could allow for targeting of some types of cancer cells with elevated copper levels by DSF.
No takes yet. Share an insight, caveat, or question.
Soave et al. (2016) conducted a review in Cancer. Disulfiram was evaluated. Disulfiram, an FDA-approved anti-alcoholism drug, shows potential as an anticancer agent by chelating elevated copper levels in cancer cells to form cytotoxic complexes.
Synapse has enriched 10 related papers. Consider them for comparative context: